Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 10 Jan 2025
News outlets run stories based on 30-year-old case report of accidental cancer transplantation
Read Full News8 Pulmonology Headlines You Missed in Q3 2026
PROPEL will test imeroprubart, an investigational FcRn blocker, against placebo in adults with mild to severe generalized myasthenia gravis.
Here's some of what is coming soon to NeurologyLive® this week.
New analyses from the D1AMOND clinical program found that 69.8% of participants achieved a clinically meaningful reduction in tic severity within 8 weeks of ecopipam treatment, while an interim 18-month analysis showed sustained improvement without new safety signals.
Full results from the phase 2b LUMA showed that investigational BIIB122/DNL151 did not slow confirmed clinical worsening in early-stage Parkinson's disease compared with placebo.
Early phase 1 findings showed that the PROTAC LRRK2 degrader ARV-102 was associated with improvements in saccadic hypometria and changes in CSF markers of endolysosomal function, neuroinflammation, synaptic integrity, and axonal guidance in participants with Parkinson disease.
6 Nephrology Headlines You Missed in September 2026
1.
Weight-Based and Fixed-Dose Pembrolizumab Compared in NSCLC
2.
When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?
3.
Independent Risk Factors for "Deaths of Despair" Found.
4.
Except for Black Patients, the Rates of Gallbladder Cancer Are Stable or Declining.
5.
Risk of a second cancer after early breast cancer is low, say new findings
1.
Beating Cancer Fatigue The Most Effective Exercise Strategies for Breast Cancer Survivors
2.
HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways
3.
Tumor Microenvironment Reprogramming for Regenerative Cancer Recovery
4.
Screening Strategies in Oncology: A Subspecialty Guide to Early Detection and Better Outcomes
5.
Secure Computational Infrastructure for Collaborative Multicenter Oncology Research Without Centralizing Patient Data
1.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Symposium on Oncology, Cardiology and Critical Care Innovations
4.
International Conference on Cancer Nursing and Hematology Support
5.
International Conference on Clinical Medicine and Surgical Care
1.
Advances in Modern Cancer Treatment
2.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VII
3.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
4.
Understanding Anemia and Its Common Causes
5.
Updates on the First Line Management of ALK+ NSCLC
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge